Responding to the continued public health crisis of opioid addiction, Behavioral Health Group, LLC (BHG) announced today the opening of an addiction treatment center in Springfield, Missouri.
Drug overdose deaths in the United States exceeded 52,000 in 2015 and now claim more lives than automobile accidents. The majority of those deaths are a result of opioid drugs including prescription pain medication and heroin.
“Opioid addiction continues to ravage communities across the United States,” said Jay Higham, Chief Executive Officer of BHG. “Our Company’s mission is to expand access to evidence-based treatment in underserved markets across the United States. With this new location, BHG now operates two full service opioid addiction treatment centers in the greater Springfield area and eight in all of Missouri.”
BHG adheres to a multidisciplinary approach to addiction treatment, which includes the use of medications indicated for opioid addiction treatment, including Methadone, Suboxone and buprenorphine maintenance therapy, to treat the biochemical aspect of addiction along with counseling to address psychosocial influences. The Company’s approach to treatment is individualized under physician supervision in an outpatient setting. Early in treatment patients visit the treatment center daily to receive medication and counseling. As treatment progresses and the patient achieves greater medical and psychosocial stability the frequency of visits to the treatment center are reduced.
“The first 90 days are critical,” said Dr. Mark Carlson, Medical Director of Springfield and North Springfield Treatment Centers. “During that time we work hard to ensure the patient is responding well to the medication and improving in their lives. For patients in treatment for 90 days, we have excellent results as measured by almost all objective criteria – abstinence from drug use, improvements in employment, family dynamics and general well-being.”
In Missouri, BHG Treatment Centers are working to participate with most major medical insurance programs that cover addiction treatment. The Company’s objective is to improve access to treatment for those struggling with addiction and recognizes that participating with third party payers is an important component of that objective.
View the original article here.